Skip to content
OP
Company

Updated:

ONYX PHARMACEUTICALS INC

ONYX PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001012140, and its reported...

Overview

ONYX PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001012140, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2013-02-28, it reported annual revenue of USD 362,165,000; net income of USD -187,787,000; total assets of USD 1,351,571,000 for the fiscal period ended 2012-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
ONYX PHARMACEUTICALS INC
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
South San Francisco, CA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001012140

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2012USD$362.2M-$187.8M$1.4B$153.2M—
FY2011USD$447.2M$76.1M$1.4B$171.6M$50.5M
FY2010USD$324.5M-$84.8M$1.4B$226.3M$28.4M

FY2011. Total assets: shown as originally filed; later filings report different values for the same periods.

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
8-K8-K
SC 13G—Form SC 13G
8-KFORM 8-K
SC 13G—SCHEDULE 13G
10-Q10-Q
8-K8-K
8-K8-K
8-K8-K
8-K8-K
10-Q10-Q
8-K8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research ONYX PHARMACEUTICALS INC in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

ONYX PHARMACEUTICALS INC | Company | Altss